Venus Remedies Limited (VENUSREM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.136x

Based on the latest financial reports, Venus Remedies Limited (VENUSREM) has a cash flow conversion efficiency ratio of 0.136x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs811.10 Million ≈ $8.77 Million USD) by net assets (Rs5.94 Billion ≈ $64.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Venus Remedies Limited balance sheet quality to measure how much of total assets are equity-financed.

Venus Remedies Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Venus Remedies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Venus Remedies Limited cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Venus Remedies Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Venus Remedies Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Kardemir Karabuk Demir Celik Sanayi ve Ticaret AS Class A
IS:KRDMA
0.031x
Sern Kou Resources Bhd
KLSE:7180
-0.021x
Jiangsu Smartwin Electronics Technology Co.Ltd.
SHE:301106
N/A
First Internet Bancorp
NASDAQ:INBK
0.209x
Kumho Ind
KO:002990
0.071x
Cint Group AB
ST:CINT
0.036x
Rxsight Inc
NASDAQ:RXST
-0.041x
Vecima Networks Inc.
TO:VCM
0.092x

Annual Cash Flow Conversion Efficiency for Venus Remedies Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Venus Remedies Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see VENUSREM stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs5.61 Billion
≈ $60.66 Million
Rs909.20 Million
≈ $9.83 Million
0.162x +111.94%
2024-03-31 Rs4.88 Billion
≈ $52.73 Million
Rs372.85 Million
≈ $4.03 Million
0.076x -3.87%
2023-03-31 Rs4.60 Billion
≈ $49.78 Million
Rs366.20 Million
≈ $3.96 Million
0.080x -14.55%
2022-03-31 Rs4.40 Billion
≈ $47.63 Million
Rs410.01 Million
≈ $4.43 Million
0.093x -71.90%
2021-03-31 Rs4.00 Billion
≈ $43.29 Million
Rs1.33 Billion
≈ $14.34 Million
0.331x +39.12%
2020-03-31 Rs3.23 Billion
≈ $34.97 Million
Rs770.10 Million
≈ $8.33 Million
0.238x +74.71%
2019-03-31 Rs3.33 Billion
≈ $35.96 Million
Rs453.27 Million
≈ $4.90 Million
0.136x -4.09%
2018-03-31 Rs3.62 Billion
≈ $39.14 Million
Rs514.36 Million
≈ $5.56 Million
0.142x -35.64%
2017-03-31 Rs4.52 Billion
≈ $48.84 Million
Rs997.24 Million
≈ $10.78 Million
0.221x +106.13%
2016-03-31 Rs4.38 Billion
≈ $47.33 Million
Rs468.81 Million
≈ $5.07 Million
0.107x -27.85%
2015-03-31 Rs4.57 Billion
≈ $49.39 Million
Rs678.05 Million
≈ $7.33 Million
0.148x +30.18%
2014-03-31 Rs4.62 Billion
≈ $49.92 Million
Rs526.46 Million
≈ $5.69 Million
0.114x -17.09%
2013-03-31 Rs3.79 Billion
≈ $41.00 Million
Rs521.50 Million
≈ $5.64 Million
0.138x +1.44%
2012-03-31 Rs3.07 Billion
≈ $33.23 Million
Rs416.70 Million
≈ $4.51 Million
0.136x -13.98%
2011-03-31 Rs2.37 Billion
≈ $25.62 Million
Rs373.47 Million
≈ $4.04 Million
0.158x -14.83%
2010-03-31 Rs1.71 Billion
≈ $18.51 Million
Rs316.83 Million
≈ $3.43 Million
0.185x +35.37%
2009-03-31 Rs1.39 Billion
≈ $14.99 Million
Rs189.50 Million
≈ $2.05 Million
0.137x -36.02%
2008-03-31 Rs889.86 Million
≈ $9.62 Million
Rs190.17 Million
≈ $2.06 Million
0.214x -50.89%
2007-03-31 Rs551.31 Million
≈ $5.96 Million
Rs239.88 Million
≈ $2.59 Million
0.435x +58.20%
2006-03-31 Rs318.96 Million
≈ $3.45 Million
Rs87.73 Million
≈ $948.76K
0.275x --

About Venus Remedies Limited

NSE:VENUSREM India Drug Manufacturers - Specialty & Generic
Market Cap
$228.63 Million
Rs21.14 Billion INR
Market Cap Rank
#15970 Global
#825 in India
Share Price
Rs1581.60
Change (1 day)
+2.75%
52-Week Range
Rs431.30 - Rs1947.00
All Time High
Rs1947.00
About

Venus Remedies Limited engages in the pharmaceutical business in India and internationally. It is involved in the research and development of solutions focusing on antimicrobial resistance and oncology. The company also offers analgesic, analgesic and antipyretic, antibiotic, anticoagulant, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormo… Read more